JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Short Interest Down 5.9% in December

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRFGet Rating) was the target of a significant drop in short interest in December. As of December 30th, there was short interest totalling 330,400 shares, a drop of 5.9% from the December 15th total of 351,100 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is presently 3,304.0 days.

JCR Pharmaceuticals Price Performance

OTCMKTS:JCRRF opened at $19.24 on Wednesday. The stock’s 50-day simple moving average is $19.24 and its 200 day simple moving average is $19.13. JCR Pharmaceuticals has a twelve month low of $19.24 and a twelve month high of $19.24.

JCR Pharmaceuticals Company Profile

(Get Rating)

JCR Pharmaceuticals Co, Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.

Further Reading

Receive News & Ratings for JCR Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JCR Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.